These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 15887246

  • 1. Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.
    Bonadona V, Sinilnikova OM, Chopin S, Antoniou AC, Mignotte H, Mathevet P, Brémond A, Martin A, Bobin JY, Romestaing P, Raudrant D, Rudigoz RC, Léoné M, Chauvin F, Easton DF, Lenoir GM, Lasset C.
    Genes Chromosomes Cancer; 2005 Aug; 43(4):404-13. PubMed ID: 15887246
    [Abstract] [Full Text] [Related]

  • 2. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [Abstract] [Full Text] [Related]

  • 3. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
    Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, Easton DF, Venter DJ.
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):741-7. PubMed ID: 10498392
    [Abstract] [Full Text] [Related]

  • 4. Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2.
    Domchek SM, Gaudet MM, Stopfer JE, Fleischaut MH, Powers J, Kauff N, Offit K, Nathanson KL, Robson M.
    Breast Cancer Res Treat; 2010 Jan; 119(2):409-14. PubMed ID: 19885732
    [Abstract] [Full Text] [Related]

  • 5. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A.
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [Abstract] [Full Text] [Related]

  • 6. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
    Antoniou AC, Durocher F, Smith P, Simard J, Easton DF, INHERIT BRCAs program members.
    Breast Cancer Res; 2006 Apr; 8(1):R3. PubMed ID: 16417652
    [Abstract] [Full Text] [Related]

  • 7. BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.
    Lalloo F, Varley J, Moran A, Ellis D, O'dair L, Pharoah P, Antoniou A, Hartley R, Shenton A, Seal S, Bulman B, Howell A, Evans DG.
    Eur J Cancer; 2006 May; 42(8):1143-50. PubMed ID: 16644204
    [Abstract] [Full Text] [Related]

  • 8. Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations.
    Seymour IJ, Casadei S, Zampiga V, Rosato S, Danesi R, Scarpi E, Falcini F, Strada M, Morini N, Naldoni C, Amadori D, Calistri D.
    Breast Cancer Res Treat; 2008 Nov; 112(2):343-9. PubMed ID: 18092194
    [Abstract] [Full Text] [Related]

  • 9. Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients.
    Choi DH, Lee MH, Bale AE, Carter D, Haffty BG.
    J Clin Oncol; 2004 May 01; 22(9):1638-45. PubMed ID: 15117986
    [Abstract] [Full Text] [Related]

  • 10. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
    Jernström H, Lubinski J, Lynch HT, Ghadirian P, Neuhausen S, Isaacs C, Weber BL, Horsman D, Rosen B, Foulkes WD, Friedman E, Gershoni-Baruch R, Ainsworth P, Daly M, Garber J, Olsson H, Sun P, Narod SA.
    J Natl Cancer Inst; 2004 Jul 21; 96(14):1094-8. PubMed ID: 15265971
    [Abstract] [Full Text] [Related]

  • 11. Does family history predict the age at onset of new breast cancers in BRCA1 and BRCA2 mutation-positive families?
    Panchal S, Bordeleau L, Poll A, Llacuachaqui M, Shachar O, Ainsworth P, Armel S, Eisen A, Sun P, Narod SA.
    Clin Genet; 2010 Mar 21; 77(3):273-9. PubMed ID: 20002453
    [Abstract] [Full Text] [Related]

  • 12. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study.
    Jacobi CE, Nagelkerke NJ, van Houwelingen JH, de Bock GH.
    Cancer Epidemiol Biomarkers Prev; 2006 Mar 21; 15(3):429-36. PubMed ID: 16537697
    [Abstract] [Full Text] [Related]

  • 13. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
    Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, LaPolla J, Hoffman M, Martino MA, Wakeley K, Wilbanks G, Nicosia S, Cantor A, Sutphen R.
    Cancer; 2005 Dec 15; 104(12):2807-16. PubMed ID: 16284991
    [Abstract] [Full Text] [Related]

  • 14. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM.
    Breast Cancer Res Treat; 2009 May 15; 115(1):51-5. PubMed ID: 18483852
    [Abstract] [Full Text] [Related]

  • 15. Similar contributions of BRCA1 and BRCA2 germline mutations to early-onset breast cancer in Germany.
    Hamann U, Liu X, Bungardt N, Ulmer HU, Bastert G, Sinn HP.
    Eur J Hum Genet; 2003 Jun 15; 11(6):464-7. PubMed ID: 12774040
    [Abstract] [Full Text] [Related]

  • 16. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
    Tryggvadottir L, Sigvaldason H, Olafsdottir GH, Jonasson JG, Jonsson T, Tulinius H, Eyfjörd JE.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):116-22. PubMed ID: 16418514
    [Abstract] [Full Text] [Related]

  • 17. Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus.
    Loizidou M, Marcou Y, Anastasiadou V, Newbold R, Hadjisavvas A, Kyriacou K.
    Clin Genet; 2007 Feb 18; 71(2):165-70. PubMed ID: 17250666
    [Abstract] [Full Text] [Related]

  • 18. CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers.
    Palanca Suela S, Esteban Cardeñosa E, Barragán González E, de Juan Jiménez I, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E, Montalar Salcedo J, Castel Sánchez V, Bolufer Gilabert P, Group for Assessment of Hereditary Cancer of Valencia Community.
    Breast Cancer Res Treat; 2010 Jan 18; 119(1):87-93. PubMed ID: 19214744
    [Abstract] [Full Text] [Related]

  • 19. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
    Giannini G, Capalbo C, Ristori E, Ricevuto E, Sidoni T, Buffone A, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A.
    Breast Cancer Res Treat; 2006 Nov 18; 100(1):83-91. PubMed ID: 16847550
    [Abstract] [Full Text] [Related]

  • 20. The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.
    Li WF, Hu Z, Rao NY, Song CG, Zhang B, Cao MZ, Su FX, Wang YS, He PQ, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Liu XY, Zhou J, Wang L, Zhao L, Liu YB, Yuan WT, Yang L, Shen ZZ, Huang W, Shao ZM.
    Breast Cancer Res Treat; 2008 Jul 18; 110(1):99-109. PubMed ID: 17851763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.